Literature DB >> 35006487

A Protective Role of Okadaic Acid in Liver Injury Induced by Amoxicillin.

D Li1, W Shi1, X Lu1, Z Liu1, S Zhang1, Y Sun1, W Shi1, X Zhu2.   

Abstract

This study was performed to investigate whether okadaic acid (200 ng/kg) produces a protective effect in experimental liver injury induced by intragastric administration of 1000, 2000, and 4000 mg/kg amoxicillin in Sprague-Dawley rats (n=50). The control group was given carboxymethylcellulose sodium solution. Liver injury was assessed by the relative organ weight index, serum ALT activity, and liver malondialdehyde content. Histopathological examination of the liver from rats treated with amoxicillin revealed cell swelling, congestion, apoptosis, and necrosis. The relative liver weight index, ALT activity, and liver malondialdehyde content in these animals were higher than in the control. Administration of okadaic acid reduced the degree of amoxicillin-induced damage to hepatocytes. Thus, okadaic acid can alleviate liver injury caused by amoxicillin.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ALT; amoxicillin; liver injury; okadaic acid; relative organ weight index

Mesh:

Substances:

Year:  2022        PMID: 35006487     DOI: 10.1007/s10517-022-05386-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  13 in total

1.  [Cholestatic hepatitis caused by amoxicillin-clavulanate of torpid evolution].

Authors:  Judith Álvarez Otero; Lucía González González; Héctor Enríquez Gómez; Javier de la Fuente Aguado
Journal:  Enferm Infecc Microbiol Clin       Date:  2015-07-09       Impact factor: 1.731

Review 2.  Okadaic acid (OA): Toxicity, detection and detoxification.

Authors:  Ling-Ling Fu; Xiao-Yu Zhao; Lin-Dan Ji; Jin Xu
Journal:  Toxicon       Date:  2019-01-11       Impact factor: 3.033

3.  Corticosteroid therapy in a case of severe cholestasic hepatitis associated with amoxicillin-clavulanate.

Authors:  José-Ignacio Herrero-Herrero; Judit García-Aparicio
Journal:  J Med Toxicol       Date:  2010-12

4.  Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.

Authors:  D Larrey; T Vial; A Micaleff; G Babany; M Morichau-Beauchant; H Michel; J P Benhamou
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

5.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

Review 6.  Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor.

Authors:  A B Dounay; C J Forsyth
Journal:  Curr Med Chem       Date:  2002-11       Impact factor: 4.530

Review 7.  Systematic Review and Meta-Analysis: Macrolides- and Amoxicillin/Clavulanate-induced Acute Liver Injury.

Authors:  Pili Ferrer; Justyna Amelio; Elena Ballarín; Mònica Sabaté; Xavi Vidal; Marietta Rottenkolber; Sven Schmiedl; Joan-Ramon Laporte; Luisa Ibáñez
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-02-03       Impact factor: 4.080

8.  Amoxicillin-Clavulanate-Induced Liver Injury.

Authors:  Andrew S deLemos; Marwan Ghabril; Don C Rockey; Jiezhun Gu; Huiman X Barnhart; Robert J Fontana; David E Kleiner; Herbert L Bonkovsky
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

9.  Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches.

Authors:  J Lee; S C Ji; B Kim; S Yi; K H Shin; J Y Cho; K S Lim; S H Lee; S H Yoon; J Y Chung; K S Yu; H S Park; S H Kim; I J Jang
Journal:  Clin Transl Sci       Date:  2016-10-26       Impact factor: 4.689

Review 10.  Amoxicillin-clavulanate-induced Granulomatous Hepatitis: Case Report and Review of the Literature.

Authors:  Avin Aggarwal; Neha Jaswal; Richa Jain; Hussien Elsiesy
Journal:  J Clin Transl Hepatol       Date:  2019-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.